Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 06-2021 | 12-2020 | 06-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,840 | 15,618 | 12,022 | 9,545 | 2,242 |
| Receivables | 1,972 | 803 | 957 | 530 | 301 |
| Inventories | 244 | 58 | 83 | 61 | 52 |
| Other current assets | 225 | 137 | 169 | 66 | 119 |
| TOTAL | $12,281 | $16,615 | $13,231 | $10,202 | $2,714 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,854 | 73 | 205 | 0 | 235 |
| TOTAL | $3,854 | $73 | $205 | $N/A | $235 |
| Total Assets | $16,422 | $17,164 | $13,784 | $10,498 | $2,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,046 | 568 | 368 | 486 | 498 |
| Other current liabilities | 914 | 348 | 357 | 291 | 267 |
| TOTAL | $2,019 | $1,050 | $908 | $938 | $919 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 34 | 35 | N/A |
| Other Non-Current Liabilities | 78 | 7 | 4 | 658 | 1 |
| TOTAL | $233 | $25 | $89 | $820 | $95 |
| Total Liabilities | $2,252 | $1,075 | $997 | $1,758 | $1,013 |
| Shareholders' Equity | |||||
| Common Shares | 113,019 | 0 | 107,580 | 0 | 87,421 |
| Retained earnings | -107,058 | -106,906 | -102,060 | -91,224 | -90,562 |
| Other shareholders' equity | 8,209 | 122,995 | 7,267 | 99,964 | 5,099 |
| TOTAL | $14,170 | $16,089 | $12,787 | $8,740 | $1,958 |
| Total Liabilities And Equity | $16,422 | $17,164 | $13,784 | $10,498 | $2,971 |